We found that high PRS patients had higher immune infiltration scores but more tumor-promoting cells (such as M2 macrophages and neutrophils), while low PRS patients had more cytotoxic cells (such as CD8+ T cells and follicular helper CD4+ T cells). Here, CD8A is linked to neoplasm.